{"log_id": 5374969838083517235, "direction": 0, "words_result_num": 35, "words_result": [{"probability": {"variance": 0, "average": 0.994776, "min": 0.994776}, "location": {"width": 25, "top": 49, "height": 23, "left": 1186}, "words": "督"}, {"probability": {"variance": 0, "average": 0.999797, "min": 0.999797}, "location": {"width": 30, "top": 89, "height": 29, "left": 1170}, "words": "明"}, {"probability": {"variance": 0.002171, "average": 0.989911, "min": 0.681255}, "location": {"width": 921, "top": 125, "height": 55, "left": 183}, "words": "每日最大推荐剂量的460倍或婴幼儿每日最大推荐剂量的190倍)。啮齿动物中,急毒性靶器官为中枢"}, {"probability": {"variance": 0, "average": 0.927907, "min": 0.927907}, "location": {"width": 31, "top": 131, "height": 30, "left": 1169}, "words": "缝"}, {"probability": {"variance": 7e-06, "average": 0.99841, "min": 0.98971}, "location": {"width": 337, "top": 176, "height": 37, "left": 180}, "words": "神经系统,多剂量毒性靶器官为肝脏"}, {"probability": {"variance": 1e-05, "average": 0.998216, "min": 0.985311}, "location": {"width": 881, "top": 227, "height": 50, "left": 218}, "words": "遗传毒性:本品Ames试验、人淋巴细胞染色体畸变试验、小鼠淋巴瘤试验和大鼠微核试验结果均"}, {"probability": {"variance": 0, "average": 0.999494, "min": 0.998681}, "location": {"width": 66, "top": 277, "height": 26, "left": 176}, "words": "为阴性"}, {"probability": {"variance": 6.1e-05, "average": 0.996749, "min": 0.956299}, "location": {"width": 880, "top": 325, "height": 54, "left": 214}, "words": "生殖毒性:小鼠生育力和一般生殖毒性试验结果提示,西替利嗪经口给药剂量达64mg/kg(按体表"}, {"probability": {"variance": 0.000491, "average": 0.994056, "min": 0.865231}, "location": {"width": 742, "top": 374, "height": 49, "left": 169}, "words": "面积折算,约相当于成人临床推荐最大日口服剂量的25倍)时,对生育力无损伤"}, {"probability": {"variance": 0.000804, "average": 0.987257, "min": 0.871377}, "location": {"width": 877, "top": 424, "height": 52, "left": 212}, "words": "小鼠、大鼠和兔经口给药剂量分别达96mg/kg、225mg/kg和135mg/kg(按体表面积折算,分别约"}, {"probability": {"variance": 0.004413, "average": 0.987199, "min": 0.583565}, "location": {"width": 732, "top": 472, "height": 45, "left": 163}, "words": "相当于成人临床推荐最大日口服剂量的40、180和220倍)时,均未见致畸作用"}, {"probability": {"variance": 0.001678, "average": 0.987037, "min": 0.747041}, "location": {"width": 879, "top": 521, "height": 50, "left": 204}, "words": "哺乳期小鼠(母鼠)经口给药剂量达96mgkg(按体表面积折算,约相当于成人临床推荐最大日口"}, {"probability": {"variance": 0.000309, "average": 0.994419, "min": 0.885267}, "location": {"width": 904, "top": 569, "height": 49, "left": 159}, "words": "服剂量的40倍)时,可引起仔鼠体重增长延迟。 Beagle犬的研究表明,给药量的大约3%经乳汁排泄"}, {"probability": {"variance": 0.003678, "average": 0.987162, "min": 0.573707}, "location": {"width": 923, "top": 616, "height": 52, "left": 156}, "words": "致癌性:大鼠连续2年经口给药的致癌性试验中,剂量达20mg/kg(按体表面积折算,约相当于成人临"}, {"probability": {"variance": 8e-06, "average": 0.998302, "min": 0.988445}, "location": {"width": 928, "top": 665, "height": 51, "left": 154}, "words": "床推荐最大日口服剂量的15倍,或婴幼儿临床推荐最大日剂量的7倍)时,未见致癌性。小鼠连续2"}, {"probability": {"variance": 0.002889, "average": 0.97847, "min": 0.713992}, "location": {"width": 926, "top": 713, "height": 52, "left": 152}, "words": "年经口给药的致癌性试验中,剂量达16mg/kg(按体表面积折算:约相当于成人临床推荐最大日口服剂"}, {"probability": {"variance": 0.000267, "average": 0.995468, "min": 0.890691}, "location": {"width": 924, "top": 762, "height": 50, "left": 150}, "words": "量的6倍,或婴幼儿临床推荐最大日剂量的3倍)时,可引起雄性动物良性肝肿瘤的发生率增加;剂量"}, {"probability": {"variance": 0.003373, "average": 0.980139, "min": 0.742718}, "location": {"width": 745, "top": 811, "height": 45, "left": 147}, "words": "达4mg/kg(按体表面积折算:约相当于成人临床推荐最大日口服剂量的2倍,或"}, {"probability": {"variance": 4e-05, "average": 0.994763, "min": 0.983541}, "location": {"width": 97, "top": 832, "height": 27, "left": 976}, "words": "幼儿临床推"}, {"probability": {"variance": 0.022265, "average": 0.924515, "min": 0.360644}, "location": {"width": 896, "top": 850, "height": 81, "left": 141}, "words": "荐最大日剂量)时,见肝肿瘤发生率的增加:上述发现的临床意义尚不清京韩"}, {"probability": {"variance": 3e-06, "average": 0.998483, "min": 0.995441}, "location": {"width": 140, "top": 908, "height": 29, "left": 149}, "words": "【药代动力学"}, {"probability": {"variance": 0.001339, "average": 0.988856, "min": 0.778166}, "location": {"width": 738, "top": 956, "height": 47, "left": 184}, "words": "口服盐酸西替利嗪在5~60mg剂量范围内,血浆浓度水平和给药剂量线性关系"}, {"probability": {"variance": 0.01053, "average": 0.963587, "min": 0.403516}, "location": {"width": 884, "top": 1004, "height": 50, "left": 180}, "words": "血浆清除半衰期大约为10小时,表观分布容积为0.5L/kg。在每天服用10mg连续服用10天盐酸"}, {"probability": {"variance": 0.001302, "average": 0.987734, "min": 0.765566}, "location": {"width": 929, "top": 1052, "height": 49, "left": 135}, "words": "西替利嗪后,未发现蓄积。稳态血药浓度峰值约为300ng/ml。西替利嗪和血浆蛋白结合牢固,血浆蛋"}, {"probability": {"variance": 0.001801, "average": 0.988039, "min": 0.756599}, "location": {"width": 928, "top": 1100, "height": 48, "left": 134}, "words": "白结合率为93%。西替利嗪的代谢无首过效应,给药剂量的三分之二以原形药物由尿液排出西替利"}, {"probability": {"variance": 0.001282, "average": 0.993083, "min": 0.758711}, "location": {"width": 918, "top": 1148, "height": 48, "left": 131}, "words": "嗪的吸收不受进食影响。西替利嗪的溶液剂、胶囊和片剂的生物利用度相仿,个体间的吸收非常一致"}, {"probability": {"variance": 0.000956, "average": 0.989705, "min": 0.79469}, "location": {"width": 886, "top": 1196, "height": 48, "left": 170}, "words": "7至12岁儿童患者口服单剂量5mg西替利嗪胶囊,Cmax均值为275ng/mL,基于交叉试验比较且"}, {"probability": {"variance": 0.00153, "average": 0.987596, "min": 0.745625}, "location": {"width": 928, "top": 1244, "height": 48, "left": 128}, "words": "权重化的儿童人群的表观全身清除率比成人高33%、消除半衰期比成人短33%:2至5岁儿童患者口服"}, {"probability": {"variance": 0.000159, "average": 0.993835, "min": 0.916704}, "location": {"width": 927, "top": 1294, "height": 46, "left": 127}, "words": "单剂量5mg西替利嗪,Cmax均值为660ng/mL,基于交叉试验比较且权重化的儿童人群的表观全身清"}, {"probability": {"variance": 0.00717, "average": 0.969807, "min": 0.43782}, "location": {"width": 930, "top": 1341, "height": 48, "left": 122}, "words": "除率比成人高81~111%、消除半衰期比成人短33%~1%:6至23个月婴幼儿患者按0.25mg/kg单剂"}, {"probability": {"variance": 0.005715, "average": 0.980066, "min": 0.618625}, "location": {"width": 440, "top": 1389, "height": 39, "left": 122}, "words": "量口服西替利嗪口服溶液(平均剂量为0.23mg)"}, {"probability": {"variance": 0.017972, "average": 0.953693, "min": 0.410781}, "location": {"width": 420, "top": 1399, "height": 38, "left": 628}, "words": "均值为390ng/mL,基于交叉试验比较且权化"}, {"probability": {"variance": 0.00023, "average": 0.99518, "min": 0.89613}, "location": {"width": 930, "top": 1439, "height": 45, "left": 117}, "words": "的儿童人群的表观全身清除率比成人高304%、消除半衰期比成人短63%。6个月至2岁儿童服用最大"}, {"probability": {"variance": 0.014078, "average": 0.956701, "min": 0.485271}, "location": {"width": 920, "top": 1487, "height": 47, "left": 116}, "words": "剂量西替利嗪溶液(每次2.5mg,每日两次)时的AUC1均值预计是成人每日服用一次10mg西替和"}, {"probability": {"variance": 0.004165, "average": 0.962295, "min": 0.81677}, "location": {"width": 246, "top": 1538, "height": 28, "left": 114}, "words": "嗪时AUCu均值的2倍多"}], "language": 3}